HTG Molecular Diagnostics, Inc.

HTG Molecular Diagnostics, Inc.

HTG Molecular Diagnostics, Inc.

Overview
Date Founded

1997

Headquarters

2711 Centerville Road,Suite 400,Wilmington, DE 19808

Type of Company

Public

Employees (Worldwide)

98

Industries

Biotechnology
IT Consulting & Services
Medical Support Services

Company Description

HTG Molecular Diagnostics, Inc. engages in the provision of molecular technology solutions that facilitates molecular profiling. Its customers include biopharmaceutical companies, academic research centers, and molecular testing laboratories. The company was founded by Bruce E. Seligmann in October 1997 and is headquartered in Tucson, AZ.

Contact Data
Trying to get in touch with decision makers at HTG Molecular Diagnostics, Inc.? Subscribe today to access their professional contact information.
Executives & Employees

Chief Executive Officer

President & Chief Operating Officer

Senior Vice President & Chief Financial Officer

Senior Vice President & Chief Legal Counsel

Senior Vice President of Medical & Scientific Affairs

Vice President-Regulatory Affairs & Quality System

Executive Director, US Business Development

Vice President of North American Capital Sales-Htg Edgeseq Platform

Manager-Marketing & Communications

Board of Directors

Managing Director & Founding Partner at BAR Capital Management LLC

Former President & Chief Executive Officer at Vermillion, Inc.

Chief Executive Officer at HTG Molecular Diagnostics, Inc.

President & Chief Executive Officer at bioTheranostics, Inc.

Co-Founder at Solstice Capital LLC

Founder at TissueNetix, Inc.

Chief Executive Officer at Gensignia, Inc.

Paths to HTG Molecular Diagnostics, Inc.
Potential Connections via
Relationship Science
You
HTG Molecular Diagnostics, Inc.
Owners & Shareholders
Details Hidden

Private Wealth Partners investment recommendations generally include advice regarding: exchange-listed securities; securities traded OTC; foreign issuers; warrants; corporate debt securities (other than commercial paper); municipal securities; mutual fund shares; US governmental securities; options contracts on securities and commodities, and interests in partnerships investing in real estate and oil & gas.

Details Hidden

Perkins Capital Management seeks to generate a positive real rate of return over an extended period of years for their clients. Investment strategies vary based on the type of account and the client's investment objectives, as well as the style of the individual portfolio manager. the firm's two main account types are equity and balanced.Perkins' approach to equity investing can be characterized as a search for opportunity. Their primary focus is on companies which appear to be undergoing positive change that may not be recognized in the market place. Such changes include new products, processes, strategies or management. They also search for companies that are likely candidates for acquisition by another company. Situations like this could provide higher earnings, and when acknowledged by others in the market place, could result in a higher price earnings ratio. Generally, equity investments will be held for a longer period of time in individual (taxable) accounts than they will be held in a pension or IRA (tax deferred) account. This provides the client with potentially lower capital gains on their taxable accounts.Perkins' fixed income investment approach seeks maximum income consistent with high quality investments. In their balanced accounts, the firm analyzes the outlook for both short-term and long-term interest rates. Perkins assesses both the domestic and international economic scene. In their opinion, the most important factors when selecting fixed income securities are the credit rating, yield curve analysis and liquidity. Perkins prefers a minimum credit rating of A by Moody’s or Standard & Poor’s rating service. They analyze the yield curves of government, corporate, and municipal bonds looking for inequities in yields which may provide an opportunity. Assessing liquidity requires that the security have excellent marketability.

Details Hidden

Private Wealth Partners investment recommendations generally include advice regarding: exchange-listed securities; securities traded OTC; foreign issuers; warrants; corporate debt securities (other than commercial paper); municipal securities; mutual fund shares; US governmental securities; options contracts on securities and commodities, and interests in partnerships investing in real estate and oil & gas.

Recent Transactions
Details Hidden

HTG Molecular Diagnostics, Inc. issued Common Stock

Details Hidden

HTG Molecular Diagnostics, Inc. issued Common Stock

Details Hidden

HTG Molecular Diagnostics, Inc. raised money in a private placement transaction

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Escrow Agent

Advised onHTG Molecular Diagnostics, Inc. issued Common Stock

Auditor

Advised onHTG Molecular Diagnostics, Inc. issued Common Stock

Legal Advisor

Advised onHTG Molecular Diagnostics, Inc. issued Common Stock

Managing Director

Advised onHTG Molecular Diagnostics, Inc. issued Common Stock

Legal Advisor

Advised onHTG Molecular Diagnostics, Inc. issued Common Stock

Associate

Advised onHTG Molecular Diagnostics, Inc. issued Common Stock

Advisors & Consultants
Publicist

Vice President at Westwicke Partners LLC

Publicist

Managing Director & Relationship Manager at LifeSci Advisors LLC

Clients

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Bristol-Myers Squibb Company Our company has a strong legacy of innovation that began in New York in 1858 when Edward R. Squibb, M.D., founded a pharmaceutical company in Brooklyn, and in 1887 when two friends, William McLaren Bristol and John Ripley Myers purchased a struggling drug manufacturing firm in Clinton. Together, they laid the foundation for our company today — a global BioPharma leader that continues this legacy of innovation.

Merck KGaA engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, and Performance Materials. The Healthcare sector discovers, develops, and manufactures prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector develops specialty chemicals and materials for demanding applications. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.

Key Stats and Financials As of 2017
Market Capitalization
$90.2M
Total Enterprise Value
$20.3M
Earnings Per Share
$-1.79
Revenue
$14.8M
EBITDA
$-16.5M
EBITDAMargin
-111.66%
Net Profit
$-19M
Total Equity
$-3.06M
Total Debt
$8.75M
TEVNet Income
-1.07x
Debt TEV
0.43x
Enterprise Value Sales
1.38x
Three Year Compounded Annual Growth Rate Of Revenue
64.28%
Five Year Compounded Annual Growth Rate Of Revenue
42.85%
Investors
Details Hidden

Founder at Systems Integration Drug Discovery Co., Inc.

Details Hidden

SR One focuses on investments in early-stage healthcare companies. The firm invests globally with a focus on North America and Europe. They invest at all stages of a company's development. SR One targets companies involved in drug discovery, drug development and tools that facilitate the discovery and development of new drugs. They are interested in companies with products that are in preclinical development through clinical proof-of-concept. SR One looks for investments that provide attractive financial returns and significant strategic value. The firm leads investments and works with other financial or strategic investors to syndicate deals. They are active investors and typically take board of directors or board observer seats. SR One is structured as an evergreen fund. They place approximately $25 million to $50 million each year, including follow-on investments in their portfolio companies. SR One invests between $500,000 and $5 million in each round of financing.

Details Hidden

Solstice Capital focuses on investments in seed- and early-stage companies in the areas of alternative energy, education, the environment, life sciences and information technology.Half of the firm's investments focus on the information technology sector. Their remaining activities focus on socially responsible investments in alternative energy, the environment, the life sciences and education. Solstice Capital looks for companies with experienced management teams. They also consider a company's products or services and their relationship to accessible markets. Solstice Capital seeks companies with technology, distribution arrangements or other factors that provide long-term sustainable competitive advantages. The firm also considers change factors such as technological or societal shifts that are creating the opportunity for a new entrant into the market.Initial investments range from $500,000 to $1 million. The firm participates in larger deals in conjunction with other venture capital firms, investors and angel groups. Most of the firm's investments are in companies located in the Northeastern and Southwestern regions of the US. The firm is a major investor in the Tucson market and in other areas of Arizona. They do consider investments throughout the US.

Suppliers
Illumina, Inc. Medical Support Services | San Diego, California

Illumina, Inc. engages in the development and manufacture of integrated systems for the analysis of genetic variation and function. It operates through the Core Illumina and Consolidated Variable Interest Entity segments (VIE). The Core Illumina segment serve customers in the research, clinical and applied markets, and enable the adoption of a genomic solutions. The Consolidated VIE segment includes activities of GRAIL and Helix. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Merck & Co., Inc. Medical Support Services | Kenilworth, NJ

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Invetech Pty Ltd. Other Manufacturing | Melbourne, VI

Invetech Pty Ltd. operates as an engineering consultancy firn. It specializes in product design, instrument development, and contract manufacturing in the healthcare markets. The firm's capabilities include fluidics, optics, motion, thermal control, consumable, industrial, experience and cartridge design, connectivity and systems integration, and quality systems. The company is headquartered in Melbourne, Australia.

Competitors
Abbott Laboratories Pharmaceuticals - Highland Park, Illinois

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Agilent Technologies, Inc. Industrial Machinery & Manufacturing - Santa Clara, CA

Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. It operates through the following segments: Life Sciences & applied markets; Diagnostics & Genomics; and Agilent CrossLab Business. The Life Sciences & Applied Markets Business segment provides application-focused solutions that include instruments, software, consumables and services that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. The Diagnostics & Genomics Business segment is comprised of five areas of activity providing solutions that include reagents, instruments, software and consumables, which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. The Agilent CrossLab Business segment spans the entire lab with its consumables and services portfolio, which is designed to improve customer outcomes. The company was founded on May 1999 and is headquartered in Santa Clara, CA.

Thermo Fisher Scientific, Inc. Industrial Machinery & Manufacturing - Chelmsford, MA

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions; Analytical Instruments; Specialty Diagnostics; and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines as well as diagnosis of disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment gives diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment involves in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded in November 2006 and is headquartered in Waltham, MA.